Vicarious Surgical makes 'significant' headcount cuts in 2nd round of layoffs this year
The Waltham medical device firm's CEO described the cuts as "pretty significant" in a call Wednesday morning. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 15, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
iCardio.ai launches apps on Butterfly Garden
Los Angeles-based startup iCardio.ai has joined Butterfly Network’s recently launched AI marketplace, Butterfly Garden. Under the terms of the agreement, iCardio.ai will deploy a suite of cardiac ultrasound AI tools in Butterfly Garden that use Butterfly’s handheld, whole-body point-of-care ultrasound (POCUS) probe. For instance, the suite features automation of preliminary echocardiographic reports of key measurements of the heart that can help detect valvular diseases, like aortic stenosis, and provide image quality assessments, Butterfly said.Butterfly launched Butterfly Garden in August to facilitate partnerships w...
Source: AuntMinnie.com Headlines - November 15, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
CFO of the Year 2023: Michael Fredrick, Francis Medical
Michael Fredrick joined Francis Medical four years ago and his timing couldn ’t have been better for the medical device company specializing in urological cancer care. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2023 Category: Pharmaceuticals Authors: Mollee Francisco Source Type: news
Millar to Acquire Sentron; Redefining MEMS Pressure Sensor Industry
HOUSTON, Nov. 13, 2023 /PRNewswire/ -- Millar, OEM solutions provider and leader in pressure sensor enabled medical devices for over 54 years, announces its strategic intention to acquire Sentron, a renowned and fully integrated pressure and pH sensor manufacturing company headquartered... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 13, 2023 Category: Pharmaceuticals Tags: TNM Source Type: news
IlluminOss Medical Breaks New Ground in Humerus Fracture Repair
EAST PROVIDENCE, R.I., Nov. 13, 2023 /PRNewswire/ -- IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, is addressing an unmet need in the burgeoning senior population. "The latest stats from the National Osteoporosis Foundation are that... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 13, 2023 Category: Pharmaceuticals Tags: SCZ Source Type: news
Zynex Submits FDA Application for its Next Generation NMES Device
ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 13, 2023 Category: Pharmaceuticals Tags: FDA PDT Source Type: news
CMS: Medicare Program; Calendar Year (CY) 2024 Home Health (HH) Prospective Payment System Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin Items and Services; Hospice Informal Dispute Resolution and Special Focus Program Requirements, Certain Requirements for Durable Medical Equipment Prosthetics and Orthotics Supplies; and Provider and Supplier Enrollment Requirements
Notice of final rule from the Centers for Medicare& Medicaid Services (CMS) updating the home health and home infusion therapy services payment rates for calendar year (CY) 2024. This rule also finalizes proposals to rebase and revise the home health market basket; revise the labor-related share; update the Home Health Quality Reporting Program (HH QRP) requirements; update the expanded Home Health Value-Based Purchasing (HHVBP) Model; and add an informal dispute resolution (IDR) and special focus program (SFP) for hospice, among other things. Also discusses comments received regarding access to home health aide services. ...
Source: Federal Register updates via the Rural Assistance Center - November 13, 2023 Category: Rural Health Source Type: news
NovaSterilis Collaborates with Renowned Surgeon, Dr. Jason Spector, and NYS Center for Advanced Technology at Cornell University
NovaSterilis, a leading innovator in medical device sterilization using supercritical carbon dioxide ("scCO2"), announces a collaboration with Dr. Jason Spector, M.D., Professor of Surgery and Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine, through... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 9, 2023 Category: Pharmaceuticals Tags: LIC Source Type: news
Why Is Medical Device Giant Becton, Dickinson Stock Trading Lower Today?
Becton, Dickinson, and Company BDX posted Q4 adjusted EPS of $3.42, slightly missing the consensus of $3.43. BD reported sales of $5.09 billion, up 6.8% Y/Y (+5.9 on constant currency), slightly beating the consensus of $5.02 billion. Q4 revenue from base business (which excludes COVID-only…#becton #bdx #eps #q4 #dividend (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2023 Category: Consumer Health News Source Type: news
New Dentsply Sirona sustainability report shows Company made solid progress against goals for the third year in a row
Dentsply Sirona is committed to driving sustainability internally and enabling the industry to advance with confidence towards a more sustainable future. Three years ago, the company launched its sustainability strategy "BEYOND: Taking action for a brighter world" to positively contribute to environmental, social, and governance goals.CHARLOTTE, N.C., Nov. 6, 2023/PRNewswire/ -- Dentsply Sirona, the world ' s largest manufacturer of professional dental products and technologies, published its third sustainability report in September, highlighting that the Company has continued to successfully take action to drive sust...
Source: Dental Technology Blog - November 9, 2023 Category: Dentistry Source Type: news
Deep-learning model predicts bone density on chest x-rays
Monday, November 27 | 11:00 a.m.-12:00 p.m. | M4-SSMK03-4 | Room E450AA deep-learning AI model will be presented in this session that can predict bone mineral density T-scores from chest x-rays.Presenter Yoichi Sato, MD, of Tokyo Shinjuku Medical Center in Japan, and colleagues first developed the model using patient dual-energy x-ray absorptiometry (DEXA) T-scores (bone mineral density) and chest x-rays as input. They then trained the algorithm on a data set of 47,150 x-rays (23,151 patients) and validated it on an external data set of 2,914 radiographs (1,515 patients).The model achieved 79% accuracy, 96.6% sensitivity, ...
Source: AuntMinnie.com Headlines - November 9, 2023 Category: Radiology Authors: Will Morton Tags: 2023 Digital X-Ray Preview Source Type: news
Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Investor Update - November 9, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Elecsys NfL test, an important aid for those living with Multiple Sclerosis, is granted FDA Breakthrough Device Designation
Roche Elecsys NfL aids in detection of disease activity in adults with Multiple Sclerosis supporting better disease management decisionsElecsys NfL offers a minimally invasive testing option that can provide rapid answers to patients and caregiversNfL has the potential to provide patient insights for other neurological conditions such as Alzheimer ’s and Huntington’s diseasesBasel, 9 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys ® Neurofilament Light Chain (NfL) test for Multiple Sclerosis (MS) received Breakthrough Device Designation from the U.S. Food and Drug Administration (FD...
Source: Roche Media News - November 9, 2023 Category: Pharmaceuticals Source Type: news
FTC Disputes Over 100 Medical Patents Listed With FDA FTC Disputes Over 100 Medical Patents Listed With FDA
The US Federal Trade Commission on Tuesday said it sent letters to medical device companies and drugmakers disputing the accuracy or relevance of 110 patents that could lead to delays in generic competition.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2023 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
Approval of the Paradise Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.
PALO ALTO, Calif., Nov. 8, 2023 -- (Healthcare Sales & Marketing Network) -- Recor Medical, Inc. ("Recor... Devices, Cardiology, FDA Recor Medical, Otsuka Medical Devices, Paradise, Renal Denervation, hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2023 Category: Pharmaceuticals Source Type: news
